- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Akari Therapeutics Partners with WuXi XDC to Accelerate Development of Novel PH1 Payload | ||
| Mo | Thermo Fisher Introduces Gibco CTS Compleo Fill and Finish System | ||
| Mo | Scinai Completes Corporate Reorganization Separating CDMO and R&D Operations | ||
| Mo | Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics for $2.9B | ||
| 02.04. | CellCarta, Pillar Biosciences Partner to Expand Access to Tumor Profiling | ||
| 02.04. | Merck's Keytruda Approved in EU for Treatment of Recurrent Ovarian Cancers | ||
| 02.04. | PharmaEssentia to Establish New Manufacturing Facility in Puerto Rico | ||
| 02.04. | Lilly to Acquire Centessa Pharmaceuticals | ||
| 01.04. | Korsana Biosciences and Cyclerion Therapeutics to Merge, Operate Under Korsana Name | ||
| 01.04. | Symbiosis Expands Quality Control Lab | ||
| 01.04. | ROIS Expands U.S. Footprint with Acquisition of Phoenix Manufacturing Site | ||
| 01.04. | Neuland Laboratories Names Saharsh Davuluri as CEO and Managing Director | ||
| 01.04. | NJ Bio, Aji Bio-Pharma Partner to Support ADC Development | ||
| 01.04. | Janux Unveils Development Candidate in Bristol Myers Squibb Partnership, Worth $35M Milestone | ||
| 01.04. | Adragos Completes Acquisition of Sanofi's Sterile Fill-Finish Site in France | ||
| 01.04. | Evotec SE Taps Dr. Ashiq H. Khan as EVP Global Head, Chief Commercial Officer | ||
| 01.04. | Genmab Appoints Margarida Duarte as GM, Europe and Emerging Markets | ||
| 01.04. | Orionis Biosciences Taps Dr. Giulio Draetta as Chief Strategy Officer | ||
| 31.03. | Bracco Imaging Upgrades Geneva Site | ||
| 31.03. | Exostar Taps Amy Hogan as Its First Chief Information Officer | ||
| 31.03. | Sanofi's Rezurock Approved in EU for Treatment of Chronic Graft-Versus-Host Disease | ||
| 31.03. | Samsung Biologics Acquires GSK Maryland Manufacturing Facility | ||
| 31.03. | Torqur, Lonza Partner to Advance Oncology Drug Candidate | ||
| 31.03. | Infinimmune, Merck Partner to Discover Human Antibody Therapeutics | ||
| 31.03. | Poxel Sells Kidney-Disease Drug Candidate to Scynexis for Up to $196 Million |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.